09:43 Mon 15 Mar 2021
SkinBioTherapeutics - Exercise of Warrant
SkinBioTherapeutics plc
Exercise of Warrant
Application will be made to the London Stock Exchange to admit the 890,314 new ordinary shares resulting from the Warrant Exercise to trading on AIM. Admission of the new ordinary shares is expected to occur on or around
For the purpose of the Disclosure and Transparency Rules, following Admission the enlarged issued share capital of the Company will comprise 156,780,236 ordinary shares of
-Ends-
For more information, please contact:
SkinBioTherapeutics plc |
Tel: +44 (0) 161 468 2760 |
|
|
Cenkos Securities Plc (Nominated Adviser & Broker) |
Tel: +44 (0) 20 7397 8900 |
|
|
Instinctif Partners |
Tel: +44 (0) 20 7457 2020 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE